July 3, 2018
Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
January 23, 2018
ProMIS Neurosciences (TSX:PMN) a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, announced further...
October 26, 2017
Alzheimer's already affects nearly five million Americans, with a growing population incoming, the need for an improved treatment is a...
October 17, 2017
ProMIS Neurosciences provided an update from a preclinical study comparing PMN310 to other amyloid beta-directed antibodies combating Alzheimer's disease.
September 19, 2017
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of...
August 29, 2017
Here, the Investing News Network looks at publicly traded biotech companies listed on the TSX.
August 11, 2017
ProMIS Neurosciences shared its financial and operational results for the second quarter of 2017.